CUMYL-NBMINACA (SGT-152, Cumyl-BC
.2.1pMINACA) is a
synthetic cannabinoid
Synthetic cannabinoids, or neocannabinoids, are a class of designer drug molecules that Binding affinity, bind to the same receptors to which cannabinoids (Tetrahydrocannabinol, THC, Cannabidiol, CBD and many others) in cannabis plants attach. Th ...
compound first reported in a 2013 patent, but not identified as a
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. ...
until 2021, being identified by a forensic laboratory in Germany in February 2021.
See also
*
CUMYL-BC-HPMEGACLONE-221
*
CUMYL-3TMS-PRINACA
CUMYL-3TMS-PRINACA is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Sweden in May 2023. Along with the related compound ADMB-3TMS-PRINACA that was reported sever ...
References
Cannabinoids
Indazolecarboxamides
{{cannabinoid-stub